Total Payments
$4,698
2024 Payments
$2,797
Companies
22
Transactions
128
Medicare Patients
2,529
Medicare Billing
$436,330
Payment Breakdown by Category
Education$2,529 (53.8%)
Food & Beverage$1,971 (42.0%)
Travel$198.26 (4.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $2,529 | 3 | 53.8% |
| Food and Beverage | $1,971 | 122 | 42.0% |
| Travel and Lodging | $198.26 | 3 | 4.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $2,715 | 5 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $682.11 | 37 | $0 (2024) |
| GlaxoSmithKline, LLC. | $601.43 | 43 | $0 (2024) |
| Mylan Specialty L.P. | $99.13 | 6 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $83.49 | 6 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $78.55 | 6 | $0 (2019) |
| Grifols USA, LLC | $61.51 | 3 | $0 (2020) |
| PORTOLA PHARMACEUTICALS, INC. | $59.64 | 4 | $0 (2019) |
| Philips Electronics North America Corporation | $52.90 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $34.85 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,797 | 9 | INTUITIVE SURGICAL, INC. ($2,715) |
| 2023 | $140.11 | 6 | Actelion Pharmaceuticals US, Inc. ($73.19) |
| 2022 | $40.31 | 3 | GlaxoSmithKline, LLC. ($40.31) |
| 2021 | $104.57 | 7 | GlaxoSmithKline, LLC. ($93.02) |
| 2020 | $139.51 | 6 | Actelion Pharmaceuticals US, Inc. ($99.09) |
| 2019 | $815.57 | 52 | Actelion Pharmaceuticals US, Inc. ($298.99) |
| 2018 | $246.73 | 14 | Actelion Pharmaceuticals US, Inc. ($56.44) |
| 2017 | $413.78 | 31 | GlaxoSmithKline, LLC. ($155.07) |
All Payment Transactions
128 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $186.26 | General |
| Category: SURGERY | ||||||
| 11/18/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $2,500.00 | General |
| Category: SURGERY | ||||||
| 11/18/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: SURGERY | ||||||
| 10/18/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $6.00 | General |
| Category: SURGERY | ||||||
| 09/19/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $6.00 | General |
| Category: SURGERY | ||||||
| 09/11/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $16.80 | General |
| Category: Medical Device | ||||||
| 07/23/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $17.19 | General |
| Category: Medical Device | ||||||
| 05/07/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $33.26 | General |
| Category: Cardiology | ||||||
| 10/26/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $37.97 | General |
| Category: Cardiology | ||||||
| 09/28/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $35.22 | General |
| Category: Cardiology | ||||||
| 05/31/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Respiratory | ||||||
| 03/28/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: RESPIRATORY | ||||||
| 02/23/2023 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $14.03 | General |
| Category: HFCWO | ||||||
| 02/16/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: RESPIRATORY | ||||||
| 02/01/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: RESPIRATORY | ||||||
| 01/18/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: RESPIRATORY | ||||||
| 10/13/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: RESPIRATORY | ||||||
| 09/08/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: RESPIRATORY | ||||||
| 08/05/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: RESPIRATORY | ||||||
| 07/22/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: RESPIRATORY | ||||||
| 06/24/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: RESPIRATORY | ||||||
| 06/14/2021 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: Cardiology | ||||||
| 04/15/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 458 | 777 | $265,060 | $76,095 |
| 2022 | 13 | 525 | 808 | $265,311 | $82,428 |
| 2021 | 13 | 657 | 1,128 | $402,385 | $128,929 |
| 2020 | 13 | 889 | 1,483 | $468,907 | $148,878 |
Total Patients
2,529
Total Services
4,196
Medicare Billing
$436,330
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 108 | 189 | $49,896 | $23,263 | 46.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 42 | 114 | $109,271 | $18,003 | 16.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 56 | 161 | $40,235 | $13,898 | 34.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 90 | $17,640 | $7,704 | 43.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 39 | 43 | $17,252 | $5,256 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $6,342 | $2,177 | 34.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 24 | 29 | $3,923 | $1,174 | 29.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 24 | 30 | $2,640 | $1,167 | 44.2% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 19 | 19 | $6,593 | $1,135 | 17.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 18 | $3,250 | $1,059 | 32.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 23 | 30 | $2,010 | $501.28 | 24.9% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 18 | 20 | $4,500 | $396.80 | 8.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 13 | 13 | $1,508 | $360.49 | 23.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 140 | 227 | $59,928 | $28,081 | 46.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 46 | 122 | $73,389 | $19,778 | 26.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 77 | 150 | $31,158 | $11,026 | 35.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 60 | 66 | $24,684 | $8,488 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 49 | $9,604 | $4,244 | 44.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $5,436 | $2,110 | 38.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $4,524 | $1,875 | 41.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 29 | $4,891 | $1,533 | 31.3% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 13 | 13 | $18,460 | $1,232 | 6.7% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 18 | 19 | $6,593 | $1,220 | 18.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 38 | 54 | $3,618 | $1,002 | 27.7% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 33 | 38 | $8,550 | $925.95 | 10.8% |
About Dr. Winfred Manda, MD
Dr. Winfred Manda, MD is a Pulmonary Disease healthcare provider based in Chattanooga, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659384980.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Winfred Manda, MD has received a total of $4,698 in payments from pharmaceutical and medical device companies, with $2,797 received in 2024. These payments were reported across 128 transactions from 22 companies. The most common payment nature is "Education" ($2,529).
As a Medicare-enrolled provider, Manda has provided services to 2,529 Medicare beneficiaries, totaling 4,196 services with total Medicare billing of $436,330. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Sleep Medicine, Critical Care Medicine
- Location Chattanooga, TN
- Active Since 08/15/2006
- Last Updated 04/29/2020
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659384980
Products in Payments
- Da Vinci Surgical System (Device) $2,715
- UPTRAVI (Drug) $437.49
- TRELEGY ELLIPTA (Drug) $351.41
- ANORO (Drug) $172.66
- OPSUMIT MACITENTAN (Drug) $166.03
- LONHALA MAGNAIR (Drug) $83.49
- OPSUMIT (Drug) $73.19
- Prolastin-C Liquid (Biological) $61.51
- Respiratoriy Care Undiv (Device) $52.90
- INCRUSE (Drug) $48.66
- ANDEXXA (Biological) $46.40
- Dymista (Drug) $44.77
- STIOLTO (Drug) $36.36
- Yupelri (Drug) $34.64
- (AK6) Vest Therapy (Device) $33.99
- Adempas (Drug) $28.72
- FASENRA (Biological) $21.18
- AirMini (Device) $20.83
- Perforomist (Drug) $19.72
- ACTHAR (Biological) $19.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Chattanooga
Dr. Carlos Baleeiro, Md, MD
Pulmonary Disease — Payments: $316,465
Pulmonary Disease $316,465
Daniel Smith, Md, MD
Pulmonary Disease — Payments: $21,948
Pulmonary Disease $21,948
Dr. Upasana Bardhan Chakraborty, M.d, M.D
Pulmonary Disease — Payments: $12,425
Pulmonary Disease $12,425
John Boldt, Md, MD
Pulmonary Disease — Payments: $9,443
Pulmonary Disease $9,443
Vincent Viscomi, Md, MD
Pulmonary Disease — Payments: $8,431
Pulmonary Disease $8,431
Dr. Harsha Shanthaveerappa, Md Fccp, MD FCCP
Pulmonary Disease — Payments: $5,313
Pulmonary Disease $5,313